• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Renal Failure (2041); Pseudoaneurysm (2605); Mitral Valve Insufficiency/ Regurgitation (4451); Unspecified Tissue Injury (4559)
Event Date 12/01/2019
Event Type  Injury  
Manufacturer Narrative
Date of event - estimated.The unique device identifier (udi) is unknown because the part and lot numbers were not provided.Implant date - estimated.The clips remain in the patients.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Literature attachment.Article title: use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: a multicenter observational experience (mitra-shock study).
 
Event Description
This is filed to report the serious injuries.It was reported through a research article identifying mitraclip that may be related to the following: patient deaths, chordae rupture, acute kidney injury, unchanged mitral regurgitation, hemorrhage, pseudoaneurysm, medical intervention, hospitalization, and surgical intervention.Details are listed in the attached article, titled ¿use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: a multicenter observational experience (mitra-shock study).
 
Manufacturer Narrative
The devices were not returned for analysis.A review of the lot history records could not be performed as the part/ lot information were not provided.Unspecified tissue injury, mitral regurgitation (mr), hemorrhage, pseudoaneurysm, and renal failure, are listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.Based on the information reviewed and due to the limited information available from the article and the article covering multiple patients, a cause for the reported unspecified tissue injury, unchanged mitral regurgitation, hemorrhage, pseudoaneurysm and renal failure cannot be determined.The reported unexpected medical intervention, surgical intervention and hospitalization were results of case-specific circumstances as intervention, surgery and re-hospitalization were also reported in the article.There is no indication of a product issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key11760996
MDR Text Key248526307
Report Number2024168-2021-03696
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK CDS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/09/2021
Initial Date FDA Received05/03/2021
Supplement Dates Manufacturer Received05/24/2021
Supplement Dates FDA Received06/11/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age73 YR
-
-